VIVA1: a more invasive subclone of MDA-MB-134VI invasive lobular carcinoma cells with increased metastatic potential in xenograft models.

Br J Cancer · 2022 · PMC9276762 · PMID 35318435

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

almost reached statistical significanceP = 0.051so close (0.05 < p ≤ 0.1)

We confirmed that VIVA-43LIG cells had significantly increased cell invasion compared to the original parental MDA-MB-134VI cells (with VIVA1 also showing increased cell invasion that almost reached statistical significance in this case, P = 0.051), however, noted that VIVA-43Spl cells had similar invasion rates to the parental MDA-MB-134VI cells.

also in 378 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.